25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives (Q26774810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

2 references

7 August 2020

9 September 2020

25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

7 August 2020

magnetic resonance imaging

1 reference

9 September 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jeong Min Lee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Martin R Prince

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Thomas Frenzel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jan Endrikat

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Filipe Caseiro Alves

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Thomas M Grist

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Meng Law

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Tim Leiner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Kun-Cheng Li

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Konstantin Nikolaou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Hans H Schild

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jeffrey C Weinreb

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Kohki Yoshikawa

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Hubertus Pietsch

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

25 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 January 2016

2 references

7 August 2020

9 September 2020

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

7 August 2020

9 September 2020

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

1-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12325-015-0275-4

6 March 2020

exact match

0 references

cites work

Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Advanced techniques using contrast media in neuroimaging

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Real-time cardiovascular magnetic resonance at high temporal resolution: radial FLASH with nonlinear inverse reconstruction

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Safety of gadopentetate dimeglumine after 120 million administrations over 25 years of clinical use.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Perfusion MRI: the five most frequently asked clinical questions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Magnetic resonance spectroscopy of the breast: current status

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Quantitative multiparametric MRI of ovarian cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

PET/MR imaging: technical aspects and potential clinical applications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

28 September 2017

PET/MR: a paradigm shift

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadobutrol: a review of its use for contrast-enhanced magnetic resonance imaging in adults and children

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

MR myocardial perfusion imaging

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Magnetic resonance enterography

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

High-resolution motion compensated MRA in patients with congenital heart disease using extracellular contrast agent at 3 Tesla

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Contrast media in breast imaging

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Contrast-enhanced cardiac magnetic resonance imaging

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

A historical overview of magnetic resonance imaging, focusing on technological innovations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Advances in musculoskeletal MRI: technical considerations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

3.0T whole-heart coronary magnetic resonance angiography performed with 32-channel cardiac coils: a single-center experience

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a met

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Primovist, Eovist: what to expect?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Contemporary imaging of the renal mass.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Rapid time-resolved magnetic resonance angiography via a multiecho radial trajectory and GraDeS reconstruction

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Interest of diffusion-weighted echo-planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Time resolved contrast enhanced intracranial MRA using a single dose delivered as sequential injections and highly constrained projection reconstruction (HYPR CE).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Magnetic resonance angiography: current status and future directions.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

High relaxivity magnetic resonance imaging contrast agents. Part 1. Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

High-relaxivity magnetic resonance imaging contrast agents. Part 2. Optimization of inner- and second-sphere relaxivity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

A review of preclinical safety data for magnevist (gadopentetate dimeglumine) in the context of nephrogenic systemic fibrosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Molecular MRI of intracranial thrombus in a rat ischemic stroke model

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadolinium-based contrast agents and NSF: evidence from animal experience.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Biodistribution of gadolinium-based contrast agents, including gadolinium deposition

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Prevalence of acute adverse reactions to gadobutrol--a highly concentrated macrocyclic gadolinium chelate: review of 14,299 patients from observational trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Clinical applications of cardiac magnetic resonance imaging.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Undersampled radial MR acquisition and highly constrained back projection (HYPR) reconstruction: potential medical imaging applications in the post-Nyquist era.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Notes on "Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent".

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Magnetic resonance imaging in the assessment of ventricular remodeling and viability

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

MR angiography with blood pool contrast agents

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

MR contrast agents: physical and pharmacologic basics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Macromolecular MRI contrast agents for imaging tumor angiogenesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Magnetic resonance angiography of abdominal and lower extremity vasculature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Atherosclerotic Vascular Disease Conference: Writing Group IV: imaging

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Tissue-specific MR contrast agents

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Special focus session. MR arthrography

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Dynamic contrast-enhanced magnetic resonance imaging in oncology.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

First use of GdDTPA/dimeglumine in man.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Paramagnetic contrast agents in nuclear magnetic resonance medical imaging

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Magnetic resonance contrast media: principles and progress

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadodiamide and Dentate Nucleus T1 Hyperintensity in Patients With Meningioma Evaluated by Multiple Follow-Up Contrast-Enhanced Magnetic Resonance Examinations With No Systemic Interval Therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

The role of residual gadolinium in the induction of nephrogenic systemic fibrosis-like skin lesions in rats.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Improved 3D phase contrast MRI with off-resonance corrected dual echo VIPR

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligand

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Absolute cerebral blood flow measured by dynamic susceptibility contrast MRI: a direct comparison with Xe-133 SPECT.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Nuclear magnetic resonance imaging of the brain in multiple sclerosis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Magnetic resonance imaging and other techniques in the diagnosis of multiple sclerosis.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Gadolinium-DTPA in MR imaging of glioblastomas and intracranial metastases.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Dyke Award. Evaluation of contrast-enhanced MR imaging in a brain-abscess model.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Magnetic resonance demonstration of multiple sclerosis plaques in the cervical cord.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Image formation by induced local interactions. Examples employing nuclear magnetic resonance. 1973.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

31 May 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Relaxation Effects in Nuclear Magnetic Resonance Absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Image Formation by Induced Local Interactions: Examples Employing Nuclear Magnetic Resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Image formation in NMR by a selective irradiative process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Nobel Lecture. All science is interdisciplinary--from magnetic moments to molecules to men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Long-term retention of gadolinium in the skin of rodents following the administration of gadolinium-based contrast agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Evaluating the role of zinc in the occurrence of fibrosis of the skin: a preclinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Residual or retained gadolinium: practical implications for radiologists and our patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Magnetic resonance tomography (MRT) of intracranial tumours: initial experience with the use of the contrast medium Gadolinium-DTPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Intra-individual, randomised comparison of the MRI contrast agents gadobutrol versus gadoteridol in patients with primary and secondary brain tumours, evaluated in a blinded read

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Time-resolved contrast-enhanced MR angiography of intracranial lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Gadolinium-enhanced MR angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Peripheral vascular tree stenoses: evaluation with moving-bed infusion-tracking MR angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

The expanding prognostic role of late gadolinium enhanced cardiac magnetic resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Liver transplantation: impaired biliary excretion of gadoxate is associated with an inferior 1-year retransplantation-free survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Improved hepatic arterial phase MRI with 3-second temporal resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Fast 3D contrast enhanced MRI of the liver using temporal resolution acceleration with constrained evolution reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast-enhanced MRI: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Accuracy of Contrast-Enhanced Magnetic Resonance Imaging in Predicting Improvement of Regional Myocardial Function in Patients After Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Gadolinium-enhanced MR aortography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Accurate prostate tumour detection with multiparametric magnetic resonance imaging: dependence on histological properties.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Whole-heart cine MRI in a single breath-hold--a compressed sensing accelerated 3D acquisition technique for assessment of cardiac function

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Safety of gadobutrol, a new generation of contrast agents: experience from clinical trials and postmarketing surveillance

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Routine MR imaging protocol with breath-hold fast scans: diagnostic efficacy for focal liver lesions.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4735235

MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study

28 November 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

Multihance clinical pharmacology: biodistribution and MR enhancement of the liver

21 January 2018

1 reference

12 December 2020

NMR in cancer: XVI. FONAR image of the live human body

1 reference

12 December 2020

Enhancement of relaxation rate with paramagnetic contrast agents in NMR imaging

1 reference

12 December 2020

Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry

1 reference

12 December 2020

Bowel disease: Prospective comparison of CT and 1.5-T pre- and postcontrast MR imaging with T1-weighted fat-suppressed and breath-hold FLASH sequences

1 reference

12 December 2020

Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers

1 reference

12 December 2020

MR imaging of the breast using gadolinium-DTPA

1 reference

12 December 2020

Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of 1M gadobutrol in patients with chronic renal failure

1 reference

12 December 2020

Application of gadolinium-based contrast agents and prevalence of nephrogenic systemic fibrosis in a cohort of end-stage renal disease patients on hemodialysis

1 reference

12 December 2020

Time-resolved contrast-enhanced 3D MR angiography

1 reference

12 December 2020

Hepatobiliary MR imaging: first human experience with MnDPDP

1 reference

12 December 2020

Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector

1 reference

12 December 2020

The evaluation of musculoskeletal disease with magnetic resonance imaging

1 reference

12 December 2020

Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent

1 reference

12 December 2020

Stability of linear and macrocyclic gadolinium based contrast agents

1 reference

12 December 2020

Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients

1 reference

12 December 2020

Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts

1 reference

12 December 2020

Work in progress: potential oral and intravenous paramagnetic NMR contrast agents

1 reference

12 December 2020

Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent

1 reference

12 December 2020

Proton nuclear magnetic resonance imaging of regionally ischemic canine hearts: effect of paramagnetic proton signal enhancement

1 reference

12 December 2020

Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver

1 reference

12 December 2020

Experimental Gd-DTPA polylysine enhanced MR angiography: sequence optimization

1 reference

12 December 2020

Motion suppression in MR imaging of the liver: comparison of respiratory-triggered and nontriggered fast spin-echo sequences

1 reference

12 December 2020

Top 100 cited AJR articles at the AJR's Centennial

1 reference

12 December 2020

Gadoxetic acid disodium-enhanced magnetic resonance imaging for biliary and vascular evaluations in preoperative living liver donors: comparison with gadobenate dimeglumine-enhanced MRI

1 reference

12 December 2020

Development of a geometrically accurate imaging protocol at 3 Tesla MRI for stereotactic radiosurgery treatment planning

1 reference

12 December 2020

Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging

1 reference

12 December 2020

MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations

1 reference

12 December 2020

The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging

1 reference

12 December 2020

Perfusion MRI for Monitoring the Effect of Sorafenib on Experimental Prostate Carcinoma: A Validation Study

1 reference

12 December 2020

Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress

1 reference

12 December 2020

The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction

1 reference

12 December 2020

Clinical Functional MRI of the kidneys

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

7 January 2021

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

7 January 2021

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1007%2FS12325-015-0275-4

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1007/S12325-015-0275-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809251%20AND%20SRC:MED&resulttype=core&format=json